Tranexamic Acid in Hip and Knee Arthroplasty

Journal of the American Academy of Orthopaedic Surgeons

Volumn 23, Issue 12, 2015, Pages 732-740

  Melvin, J Stuart ^a   Stryker, Louis S ^b   Sierra, Rafael J ^c  

^a ORTHOCAROLINA HIP AND KNEE CENTER   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^c MAYO CLINIC   (United States)

Author keywords

hip arthroplasty; knee arthroplasty; Tranexamic acid

Indexed keywords

ANTIFIBRINOLYTIC AGENT; TRANEXAMIC ACID;

ADVERSE EFFECTS; BLOOD LOSS, SURGICAL; BLOOD TRANSFUSION; ECONOMICS; HIP REPLACEMENT; HUMAN; KNEE REPLACEMENT; POSTOPERATIVE HEMORRHAGE; VENOUS THROMBOEMBOLISM;

ANTIFIBRINOLYTIC AGENTS; ARTHROPLASTY, REPLACEMENT, HIP; ARTHROPLASTY, REPLACEMENT, KNEE; BLOOD LOSS, SURGICAL; BLOOD TRANSFUSION; HUMANS; POSTOPERATIVE HEMORRHAGE; TRANEXAMIC ACID; VENOUS THROMBOEMBOLISM;

EID: 84948125778     PISSN: 1067151X     EISSN: None     Source Type: Journal    
DOI: 10.5435/JAAOS-D-14-00223     Document Type: Review

References (57)

1. Kurtz SM, Ong KL, Lau E, Bozic KJ: Impact of the economic downturn on total joint replacement demand in the United States: Updated projections to 2021. J Bone Joint Surg Am 2014;96(8):624-630.
2. Cushner FD, Friedman RJ: Blood loss in total knee arthroplasty. Clin Orthop Relat Res 1991;269:98-101.
3. Sehat KR, Evans R, Newman JH: How much blood is really lost in total knee arthroplasty Correct blood loss management should take hidden loss into account. Knee 2000;7(3):151-155.
4. Bierbaum BE, Callaghan JJ, Galante JO, Rubash HE, Tooms RE, Welch RB: An analysis of blood management in patients having a total hip or knee arthroplasty. J Bone Joint Surg Am 1999;81(1):2-10.
5. Noticewala MS, Nyce JD, Wang W, Geller JA, Macaulay W: Predicting need for allogeneic transfusion after total knee arthroplasty. J Arthroplasty 2012;27(6): 961-967.
6. Friedman R, Homering M, Holberg G, Berkowitz SD: Allogeneic blood transfusions and postoperative infections after total hip or knee arthroplasty. J Bone Joint Surg Am 2014;96(4):272-278.
7. Petäjä J, Myllynen P, Myllylä G, Vahtera E: Fibrinolysis after application of a pneumatic tourniquet. Acta Chir Scand 1987;153(11-12):647-651.
8. McCormack PL: Tranexamic acid: A review of its use in the treatment of hyperfibrinolysis. Drugs 2012;72(5):585-617.
9. Yang ZG, Chen WP, Wu LD: Effectiveness and safety of tranexamic acid in reducing blood loss in total knee arthroplasty: A meta-analysis. J Bone Joint Surg Am 2012; 94(13):1153-1159.
10. Georgiadis AG, Muh SJ, Silverton CD, WeirRM, LakerMW: A prospective doubleblind placebo controlled trial of topical tranexamic acid in total knee arthroplasty. J Arthroplasty 2013;28(suppl 8):78-82.
11. Panteli M, Papakostidis C, Dahabreh Z, Giannoudis PV: Topical tranexamic acid in total knee replacement: A systematic review and meta-analysis. Knee 2013;20(5): 300-309.
12. MacGillivray RG, Tarabichi SB, Hawari MF, Raoof NT: Tranexamic acid to reduce blood loss after bilateral total knee arthroplasty: A prospective, randomized double blind study. J Arthroplasty 2011;26(1):24-28.
13. Tanaka N, Sakahashi H, Sato E, Hirose K, Ishima T, Ishii S: Timing of the administration of tranexamic acid for maximum reduction in blood loss in arthroplasty of the knee. J Bone Joint Surg Br 2001;83(5):702-705.
14. Benoni G, Fredin H: Fibrinolytic inhibition with tranexamic acid reduces blood loss and blood transfusion after knee arthroplasty: A prospective, randomised, double-blind study of 86 patients. J Bone Joint Surg Br 1996;78(3):434-440.
15. Chimento GF, Huff T, Ochsner JL Jr, Meyer M, Brandner L, Babin S: An evaluation of the use of topical tranexamic acid in total knee arthroplasty. J Arthroplasty 2013;28(suppl 8):74-77.
16. Mutsuzaki H, Ikeda K: Intra-articular injection of tranexamic acid via a drain plus drain-clamping to reduce blood loss in cementless total knee arthroplasty. J Orthop Surg Res 2012;7:32.
17. Huang Z, Ma J, Shen B, Pei F: Combination of intravenous and topical application of tranexamic acid in primary total knee arthroplasty: A prospective randomized controlled trial. J Arthroplasty 2014;29 (12):2342-2346.
18. Sarzaeem MM, Razi M, Kazemian G, Moghaddam ME, Rasi AM, Karimi M: Comparing efficacy of three methods of tranexamic acid administration in reducing hemoglobin drop following total knee arthroplasty. J Arthroplasty 2014;29(8): 1521-1524.
19. Irwin A, Khan SK, Jameson SS, Tate RC, Copeland C, Reed MR: Oral versus intravenous tranexamic acid in enhancedrecovery primary total hip and knee replacement: Results of 3000 procedures. Bone Joint J 2013;95-B(11):1556-1561.
20. Alipour M, Tabari M, Keramati M, Zarmehri AM, Makhmalbaf H: Effectiveness of oral tranexamic acid administration on blood loss after knee arthroplasty: A randomized clinical trial. Transfus Apher Sci 2013;49(3):574-577.
21. Zohar E, Ellis M, Ifrach N, Stern A, Sapir O, Fredman B: The postoperative blood-sparing efficacy of oral versus intravenous tranexamic acid after total knee replacement. Anesth Analg 2004;99 (6):1679-1683.
22. Niskanen RO, Korkala OL: Tranexamic acid reduces blood loss in cemented hip arthroplasty: A randomized, double-blind study of 39 patients with osteoarthritis. Acta Orthop 2005;76(6):829-832.
23. Zhou XD, Tao LJ, Li J, Wu LD: Do we really need tranexamic acid in total hip arthroplasty A meta-analysis of nineteen randomized controlled trials. Arch Orthop Trauma Surg 2013;133(7):1017-1027.
24. Yue C, Kang P, Yang P, Xie J, Pei F: Topical application of tranexamic acid in primary total hip arthroplasty: A randomized double-blind controlled trial. J Arthroplasty 2014;29(12):2452-2456.
25. Johansson T, Pettersson LG, Lisander B: Tranexamic acid in total hip arthroplasty saves blood and money: A randomized, double-blind study in 100 patients. Acta Orthop 2005;76(3):314-319.
26. Yamasaki S, Masuhara K, Fuji T: Tranexamic acid reduces postoperative blood loss in cementless total hip arthroplasty. J Bone Joint Surg Am 2005; 87(4):766-770.
27. Rajesparan K, Biant LC, Ahmad M, Field RE: The effect of an intravenous bolus of tranexamic acid on blood loss in total hip replacement. J Bone Joint Surg Br 2009;91 (6):776-783.
28. McConnell JS, Shewale S, Munro NA, Shah K, Deakin AH, Kinninmonth AW: Reduction of blood loss in primary hip arthroplasty with tranexamic acid or fibrin spray. Acta Orthop 2011;82(6):660-663.
29. Gill JB, Rosenstein A: The use of antifibrinolytic agents in total hip arthroplasty: A meta-analysis. J Arthroplasty 2006;21(6):869-873.
30. Chang CH, Chang Y, Chen DW, Ueng SW, Lee MS: Topical tranexamic acid reduces blood loss and transfusion rates associated with primary total hip arthroplasty. Clin Orthop Relat Res 2014;472(5):1552-1557.
31. Phillips SJ, Chavan R, Porter ML, et al: Does salvage and tranexamic acid reduce the need for blood transfusion in revision hip surgery J Bone Joint Surg Br 2006;88 (9):1141-1142.
32. Noordin S, Waters TS, Garbuz DS, Duncan CP, Masri BA: Tranexamic acid reduces allogenic transfusion in revision hip arthroplasty. Clin Orthop Relat Res 2011; 469(2):541-546.
33. Smit KM, Naudie DD, Ralley FE, Berta DM, Howard JL: One dose of tranexamic acid is safe and effective in revision knee arthroplasty. J Arthroplasty 2013;28(suppl 8):112-115.
34. Lemay E, Guay J, Côté C, Roy A: Tranexamic acid reduces the need for allogenic red blood cell transfusions in patients undergoing total hip replacement. Can J Anaesth 2004;51(1):31-37.
35. Levine BR, Haughom BD, Belkin MN, Goldstein ZH: Weighted versus uniform dose of tranexamic acid in patients undergoing primary, elective knee arthroplasty: A prospective randomized controlled trial. J Arthroplasty 2014;29 (suppl 9):186-188.
36. Ker K, Edwards P, Perel P, Shakur H, Roberts I: Effect of tranexamic acid on surgical bleeding: Systematic review and cumulative meta-analysis. BMJ 2012;344: e3054.
37. Alshryda S, Sarda P, Sukeik M, Nargol A, Blenkinsopp J, Mason JM: Tranexamic acid in total knee replacement: A systematic review and meta-analysis. J Bone Joint Surg Br 2011;93(12):1577-1585.
38. Imai N, Dohmae Y, Suda K, Miyasaka D, Ito T, Endo N: Tranexamic acid for reduction of blood loss during total hip arthroplasty. J Arthroplasty 2012;27(10): 1838-1843.
39. Tan J, Chen H, Liu Q, Chen C, Huang W: A meta-analysis of the effectiveness and safety of using tranexamic acid in primary unilateral total knee arthroplasty. J Surg Res 2013;184(2):880-887.
40. Iwai T, Tsuji S, Tomita T, Sugamoto K, Hideki Y, Hamada M: Repeat-dose intravenous tranexamic acid further decreases blood loss in total knee arthroplasty. Int Orthop 2013;37(3): 441-445.
41. Maniar RN, Kumar G, Singhi T, Nayak RM, Maniar PR: Most effective regimen of tranexamic acid in knee arthroplasty: A prospective randomized controlled study in 240 patients. Clin Orthop Relat Res 2012;470(9):2605-2612.
42. Lin PC, Hsu CH, Huang CC, Chen WS, Wang JW: The blood-saving effect of tranexamic acid in minimally invasive total knee replacement: Is an additional preoperative injection effective J Bone Joint Surg Br 2012;94(7):932-936.
43. Charoencholvanich K, Siriwattanasakul P: Tranexamic acid reduces blood loss and blood transfusion after TKA: A prospective randomized controlled trial. Clin Orthop Relat Res 2011;469(10):2874-2880.
44. Dahuja A, Dahuja G, Jaswal V, Sandhu K: A prospective study on role of tranexamic acid in reducing postoperative blood loss in total knee arthroplasty and its effect on coagulation profile. J Arthroplasty 2014;29 (4):733-735.
45. Nilsson IM: Clinical pharmacology of aminocaproic and tranexamic acids. J Clin Pathol Suppl (R Coll Pathol) 1980;14: 41-47.
46. Tuttle JR, Ritterman SA, Cassidy DB, Anazonwu WA, Froehlich JA, Rubin LE: Cost benefit analysis of topical tranexamic acid in primary total hip and knee arthroplasty. J Arthroplasty 2014;29(8): 1512-1515.
47. Vigna-Taglianti F, Basso L, Rolfo P, et al: Tranexamic acid for reducing blood transfusions in arthroplasty interventions: A cost-effective practice. Eur J Orthop Surg Traumatol 2014;24(4):545-551.
48. Gillette BP, Maradit Kremers H, Duncan CM, et al: Economic impact of tranexamic acid in healthy patients undergoing primary total hip and knee arthroplasty. J Arthroplasty 2013;28(suppl 8):137-139.
49. Gilbody J, Dhotar HS, Perruccio AV, Davey JR: Topical tranexamic acid reduces transfusion rates in total hip and knee arthroplasty. J Arthroplasty 2014;29(4): 681-684.
50. Konig G, Hamlin BR, Waters JH: Topical tranexamic acid reduces blood loss and transfusion rates in total hip and total knee arthroplasty. J Arthroplasty 2013;28(9): 1473-1476.
51. Martin JG, Cassatt KB, Kincaid-Cinnamon KA, Westendorf DS, Garton AS, Lemke JH: Topical administration of tranexamic acid in primary total hip and total knee arthroplasty. J Arthroplasty 2014;29(5):889-894.
52. Whiting DR, Gillette BP, Duncan C, Smith H, Pagnano MW, Sierra RJ: Preliminary results suggest tranexamic acid is safe and effective in arthroplasty patients with severe comorbidities. Clin Orthop Relat Res 2014;472(1):66-72.
53. Wind TC, Barfield WR, Moskal JT: The effect of tranexamic acid on blood loss and transfusion rate in primary total knee arthroplasty. J Arthroplasty 2013;28(7): 1080-1083.
54. Gillette BP, DeSimone LJ, Trousdale RT, Pagnano MW, Sierra RJ: Low risk of thromboembolic complications with tranexamic acid after primary total hip and knee arthroplasty. Clin Orthop Relat Res 2013;471(1):150-154.
55. Lecker I, Wang DS, Romaschin AD, Peterson M, Mazer CD, Orser BA: Tranexamic acid concentrations associated with human seizures inhibit glycine receptors. J Clin Invest 2012;122(12): 4654-4666.
56. Huang F, Wu D, Ma G, Yin Z, Wang Q: The use of tranexamic acid to reduce blood loss and transfusion in major orthopedic surgery: A meta-analysis. J Surg Res 2014; 186(1):318-327.
57. Sukeik M, Alshryda S, Haddad FS, Mason JM: Systematic review and metaanalysis of the use of tranexamic acid in total hip replacement. J Bone Joint Surg Br 2011;93(1):39-46.